Question 1

What are the potential side effects of valopicitabine and Pegylated Interferon Alfa?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C clinical trial (NCT00118768). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for Hepatitis C?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C clinical trial (NCT00118768). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C clinical trial (NCT00118768). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or monitoring I will need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C clinical trial (NCT00118768). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C clinical trial (NCT00118768). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C clinical trial (NCT00118768). Contact the study team or your healthcare provider for specific answers.

What this study is about